Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
21.31
+1.62 (8.23%)
At close: Mar 9, 2026, 4:00 PM EDT
21.72
+0.41 (1.92%)
After-hours: Mar 9, 2026, 7:59 PM EDT

Denali Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
3,3802,5782,9332,9663,7775,447
Upgrade
Market Cap Growth
8.76%-12.10%-1.10%-21.48%-30.66%-45.77%
Upgrade
Enterprise Value
2,4261,7501,7041,9022,7334,153
Upgrade
Last Close Price
19.6916.5120.3821.4627.8144.60
Upgrade
PS Ratio
---8.9734.82111.93
Upgrade
PB Ratio
3.032.542.382.883.625.66
Upgrade
P/TBV Ratio
3.302.542.382.883.625.66
Upgrade
EV/Sales Ratio
---5.7625.2085.35
Upgrade
Debt / Equity Ratio
0.040.040.040.050.060.07
Upgrade
Net Debt / Equity Ratio
-0.91-0.91-0.92-0.95-1.22-1.27
Upgrade
Net Debt / EBITDA Ratio
1.711.712.315.233.864.27
Upgrade
Net Debt / FCF Ratio
2.192.193.132.654.865.58
Upgrade
Asset Turnover
---0.250.080.03
Upgrade
Quick Ratio
8.858.858.1613.313.702.29
Upgrade
Current Ratio
9.169.168.4613.653.772.37
Upgrade
Return on Equity (ROE)
-45.69%-45.69%-37.40%-14.01%-32.52%-27.51%
Upgrade
Return on Assets (ROA)
-27.56%-27.56%-24.82%-9.40%-14.87%-12.29%
Upgrade
Return on Invested Capital (ROIC)
-357.54%-173.59%-200.61%---
Upgrade
Return on Capital Employed (ROCE)
-53.10%-53.10%-39.50%-18.30%-31.10%-28.80%
Upgrade
Earnings Yield
-15.30%-19.88%-14.41%-4.90%-8.63%-5.33%
Upgrade
FCF Yield
-12.60%-16.37%-12.40%-12.51%-6.95%-4.04%
Upgrade
Buyback Yield / Dilution
-4.97%-4.97%-19.73%-9.43%-3.30%-7.83%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.